Liraglutide; A new hope for obese diabetics
- A. Kumar; D. Kumar; S. Razzaque; A. Kumar; R. Kumar; M. I. Ghauri; M. Yaseen Liraglutide; A new hope for obese diabetics Journal of the Liaquat University of Medical and Health Sciences
Publication Category: Medications
3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial
- C. W. le Roux; A. Astrup; K. Fujioka; F. Greenway; D. C. W. Lau; L. Van Gaal; R. V. Ortiz; J. P. H. Wilding; T. V. Skjøth; L. S. Manning; X. Pi-Sunyer 3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial Lancet
Will medications that mimic gut hormones or target their receptors eventually replace bariatric surgery?
- A. Kokkinos; D. Tsilingiris; C. W. le Roux; F. Rubino; C. S. Mantzoros Will medications that mimic gut hormones or target their receptors eventually replace bariatric surgery? Metabolism
Metformin in women with type 2 diabetes in pregnancy (MiTy): a multicentre, international, randomised, placebo-controlled trial
- D. S. Feig; L. E. Donovan; B. Zinman; J. J. Sanchez; E. Asztalos; E. A. Ryan; I. G. Fantus; E. Hutton; A. B. Armson; L. L. Lipscombe; D. Simmons; J. F. R. Barrett; P. J. Karanicolas; S. Tobin; H. D. McIntyre; S. Y. Tian; G. Tomlinson; K. E. Murphy; D. Fei Metformin in women with type 2 diabetes in pregnancy (MiTy): a multicentre, international, randomised, placebo-controlled trial The Lancet Diabetes and Endocrinology
Liraglutide Does Not Adversely Impact Fat-Free Mass Loss
-
A. Grannell; W. P. Martin; B. Dehestani; W. Al-Najim; J. C. Murphy; C. W. le Roux
Liraglutide Does Not Adversely Impact Fat-Free Mass Loss Obesity (Silver Spring)
Liraglutide suppression of caloric intake competes with the intake-promoting effects of a palatable cafeteria diet, but does not impact food or macronutrient selection
-
K. M. Hyde; G. D. Blonde; C. W. le Roux; A. C. Spector
Liraglutide suppression of caloric intake competes with the intake-promoting effects of a palatable cafeteria diet, but does not impact food or macronutrient selection Physiol Behav
Clinical Impact of Liraglutide as a Treatment of Obesity
-
H. Alruwaili; B. Dehestani; C. W. le Roux
Clinical Impact of Liraglutide as a Treatment of Obesity Clin Pharmacol
Recent advances in peptide-based therapy for Type 2 diabetes and obesity
- J. M. Conlon; P. R. Flatt; C. J. Bailey Recent advances in peptide-based therapy for Type 2 diabetes and obesity Peptides
Efficacy of metformin and fermentable fiber combination therapy in adolescents with severe obesity and insulin resistance: study protocol for a double-blind randomized controlled trial
- E. C. Deehan; E. Colin-Ramirez; L. Triador; K. L. Madsen; C. M. Prado; C. J. Field; G. D. C. Ball; Q. Tan; C. Orsso; I. Dinu; M. Pakseresht; D. Rubin; A. M. Sharma; H. Tun; J. Walter; C. B. Newgard; M. Freemark; E. Wine; A. M. Haqq Efficacy of metformin and fermentable fiber combination therapy in adolescents with severe obesity and insulin resistance: study protocol for a double-blind randomized controlled trial Trials